| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910586585803321 |
|
|
Titolo |
Rarer arthropathies / / Vinod Ravindran, Sham Santhanam, Mohit Goyal, editors |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham, Switzerland : , : Springer, , [2022] |
|
©2022 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (260 pages) |
|
|
|
|
|
|
Collana |
|
Rare Diseases of the Immune System |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Intro -- Foreword -- Preface -- Contents -- 1: Palindromic Rheumatism -- 1.1 Introduction -- 1.2 Pathogenesis -- 1.3 Clinical Features -- 1.4 Diagnosis -- 1.4.1 Differential Diagnosis -- 1.4.2 Imaging -- 1.5 Management -- 1.6 Conclusion -- References -- 2: Sarcoid Arthropathy -- 2.1 Introduction -- 2.2 Clinical Features -- 2.2.1 Löfgren's Syndrome -- 2.2.2 Chronic Arthritis -- 2.2.2.1 Granulomatous Synovitis -- 2.2.2.2 Tenosynovitis -- 2.2.2.3 Jaccoud's Arthropathy -- 2.2.2.4 Dactylitis -- 2.2.3 Sarcoid Bone Disease -- 2.3 Diagnosis -- 2.3.1 Clinical Approach -- 2.3.2 Laboratory Investigations -- 2.3.3 Biopsy -- 2.3.4 Imaging -- 2.4 Management Strategies for Sarcoid Arthritis -- 2.4.1 Initial Treatment -- 2.4.2 Disease-modifying Agents -- 2.4.3 Biologic Therapy -- 2.5 Conclusion -- References -- 3: Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) -- 3.1 Introduction -- 3.2 Epidemiology -- 3.3 Pathogenesis -- 3.4 Pathophysiology -- 3.5 Clinical Features -- 3.6 Investigations -- 3.6.1 Laboratory Findings -- 3.6.2 Imaging -- 3.6.3 Diagnosis -- 3.7 Associated Conditions -- 3.7.1 RS3PE and Malignancies -- 3.7.2 RS3PE and Other Rheumatic Diseases -- 3.8 Differential Diagnosis -- 3.8.1 Non-rheumatic Disorders -- 3.8.2 Rheumatic Disorders -- 3.9 Management -- 3.10 Conclusion -- References -- 4: Multicentric Reticulohistiocytosis -- 4.1 Introduction -- 4.2 Clinical Features -- 4.3 Diagnosis -- 4.3.1 |
|
|
|
|
|
|
|
|
|
Laboratory Investigations -- 4.3.2 Imaging -- 4.3.3 Histopathology -- 4.4 Pathogenesis -- 4.5 Association with Other Diseases -- 4.6 Differential Diagnoses -- 4.7 Treatment -- 4.8 Conclusion -- References -- 5: SAPHO Syndrome -- 5.1 Introduction -- 5.2 Pathophysiology -- 5.3 Clinical Features -- 5.4 Diagnosis -- 5.5 Differential Diagnoses -- 5.6 Investigations -- 5.6.1 Imaging. |
5.6.1.1 Conventional Radiography -- 5.6.1.2 Computed Tomography -- 5.6.1.3 Magnetic Resonance Imaging -- 5.6.1.4 Bone Scintigraphy -- 5.6.1.5 Positron Emission Tomography -- 5.6.2 Laboratory Investigations -- 5.7 Management -- 5.8 Conclusion -- References -- 6: Basic Calcium Phosphate-Associated Arthritis -- 6.1 Introduction -- 6.2 Milwaukee Shoulder Syndrome -- 6.2.1 Historical Perspective -- 6.2.2 Clinical Features -- 6.2.3 Epidemiology -- 6.2.4 Diagnosis -- 6.2.4.1 Synovial Fluid Analysis -- 6.2.4.2 BCP Crystal Analysis -- 6.2.4.3 Imaging -- 6.2.5 Pathophysiology -- 6.2.6 Differential Diagnosis -- 6.2.7 Management -- 6.3 Calcific Periarthritis -- 6.3.1 Clinical Features -- 6.3.2 Epidemiology -- 6.3.3 Diagnosis -- 6.3.3.1 Imaging -- 6.3.3.2 Histology -- 6.3.4 Pathogenesis -- 6.3.4.1 Genetic Causes -- 6.3.4.2 Idiopathic Causes -- 6.3.5 Differential Diagnosis -- 6.3.6 Management -- 6.4 Conclusion -- References -- 7: Neuropathic Osteoarthropathy -- 7.1 Introduction -- 7.2 Epidemiology -- 7.3 Clinical Features -- 7.4 Pathogenesis -- 7.4.1 Proinflammatory State -- 7.4.2 Role of the Osteoprotegerin-RANKL-RANK Axis -- 7.4.3 Other Factors -- 7.5 Genetics -- 7.6 Diagnostic Approach -- 7.6.1 Laboratory Investigations -- 7.6.2 Nerve Conduction Study -- 7.6.3 Imaging -- 7.6.3.1 Radiography -- Spine -- Hip Joint -- Shoulder -- Elbow Joint and Wrist Joint -- Knee Joint -- Ankle and the Foot Joint -- 7.7 Treatment -- 7.7.1 General Measures -- 7.7.2 Specific Measures -- 7.7.3 Pharmacological Therapy -- 7.7.3.1 Antiresorptive Therapy -- 7.7.3.2 Anabolic Therapy -- 7.7.4 Bone Growth Stimulation -- 7.7.5 Surgical Management -- 7.7.6 Novel/Experimental Therapies for Neuropathic Osteoarthropathy -- 7.8 Conclusion -- References -- 8: Cheiroarthropathy and Other Musculoskeletal Manifestations of Diabetes. |
8.1 Introduction -- 8.2 Diabetic Cheiroarthropathy -- 8.3 Adhesive Capsulitis -- 8.4 Dupuytren's Contracture -- 8.5 Flexor Tenosynovitis -- 8.6 Carpel Tunnel Syndrome -- 8.7 Reflex Sympathetic Dystrophy -- 8.8 Hand Osteoarthritis -- 8.9 Diffuse Idiopathic Skeletal Hyperostosis -- 8.10 Diabetic Myonecrosis -- 8.11 Neuropathic Arthropathy -- 8.12 Treatment -- 8.12.1 Diabetic Cheiroarthropathy -- 8.12.2 Adhesive Capsulitis -- 8.12.3 Trigger Finger -- 8.12.4 Dupuytren's Contracture -- 8.12.5 Carpal Tunnel Syndrome -- 8.12.6 Other Conditions -- 8.13 Conclusion -- References -- 9: Hemochromatosis Arthropathy -- 9.1 Introduction -- 9.2 Pathophysiology -- 9.3 Diagnostic Delay in Genetic Hemochromatosis -- 9.4 Clinical Features of Hemochromatosis Arthropathy -- 9.5 Imaging Features of Hemochromatosis Arthropathy -- 9.6 Management -- 9.7 Unmet Needs -- 9.8 Conclusion -- References -- 10: Skeletal Fluorosis -- 10.1 Introduction -- 10.2 Fluorine in Nature -- 10.3 Pathogenesis -- 10.3.1 Effects of Fluoride on Bone Minerals -- 10.3.2 Effects of Fluoride on Bone Cells -- 10.3.3 Effects of Fluoride on Bone Architecture -- 10.3.4 Effects of Fluoride on Collagen-Mineral Interface -- 10.3.5 Skeletal Fluorosis -- 10.3.6 Histopathology -- 10.4 Clinical Features -- 10.5 Diagnosis -- 10.5.1 Laboratory Investigations -- 10.5.1.1 Fluoride or Fluorine Levels -- 10.5.1.2 Sialic Acid/Glycosaminoglycan (SA/GAG) Ratio -- 10.5.2 Imaging -- 10.5.2.1 Radiographs -- 10.5.2.2 Radionuclide Scan -- 10.6 Differential Diagnosis -- 10.7 Treatment -- 10.8 Prevention -- |
|
|
|
|
|
|
|
|
10.8.1 Defluoridation -- 10.9 Conclusion -- References -- 11: Ochronosis -- 11.1 Introduction -- 11.2 Pathogenesis -- 11.3 Clinical Features -- 11.4 Investigations -- 11.5 Imaging -- 11.5.1 Spinal Disease -- 11.5.2 Peripheral Joint Disease -- 11.6 Differential Diagnosis. |
11.7 Management -- 11.8 Conclusion -- References -- 12: Arthritis in Tuberculosis -- 12.1 Introduction -- 12.2 Epidemiology -- 12.3 Pathogenesis -- 12.4 Risk Factors -- 12.5 Clinical Manifestations -- 12.5.1 Direct Involvement of the Musculoskeletal System -- 12.5.1.1 Spondylitis (Pott's Disease) -- 12.5.1.2 Arthritis -- 12.5.1.3 Osteomyelitis -- 12.5.2 The Emergence of TB During Treatment of Rheumatic Disease -- 12.5.3 Rheumatic Disorders Precipitated by Treatment of TB -- 12.5.4 Reactive Immunological Phenomenon in the Setting of TB -- 12.6 Imaging -- 12.6.1 Conventional Radiography -- 12.6.2 MRI -- 12.7 Diagnosis -- 12.7.1 Screening Tests -- 12.7.2 Synovial Fluid Analysis -- 12.7.3 Biopsy and Culture -- 12.8 Treatment -- 12.9 Conclusion -- References -- 13: Arthritis in Leprosy -- 13.1 Introduction -- 13.2 Epidemiology -- 13.3 Pathophysiology -- 13.4 Clinical Features -- 13.4.1 Arthritis Related to Lepra Reactions -- 13.4.2 Chronic Arthritis in Leprosy -- 13.4.3 Neuropathic Arthropathy -- 13.4.4 Swollen Hands and Feet Syndrome (SHFS) -- 13.4.5 Tenosynovitis and Enthesitis -- 13.5 Diagnosis -- 13.5.1 Laboratory -- 13.5.2 Radiology -- 13.5.3 Histology -- 13.6 Differential Diagnosis -- 13.7 Management -- 13.7.1 General -- 13.7.2 Specific -- 13.7.3 Prevention -- 13.8 Conclusion -- References -- 14: Chikungunya Arthritis -- 14.1 Introduction -- 14.2 Acute Chikungunya Fever -- 14.2.1 Clinical Features -- 14.2.2 Management -- 14.2.2.1 Prevention -- 14.2.2.2 Treatment -- 14.3 Chronic Chikungunya Arthritis -- 14.3.1 Clinical Features -- 14.3.2 Investigations -- 14.3.3 Management -- 14.4 Conclusion -- References -- 15: Brucella Arthritis -- 15.1 Introduction -- 15.2 Epidemiology -- 15.3 Microbiology -- 15.4 Pathogenesis -- 15.5 Clinical Features -- 15.6 Bone and Joint Brucellosis. |
15.6.1 Brucella Spondylitis [3, 6] -- 15.6.2 Brucella Sacroiliitis -- 15.6.2.1 Differential Diagnosis of Brucella Spondylitis and Sacroiliitis -- 15.6.3 Brucella Arthritis -- 15.6.4 Brucellosis Presenting as Pyrexia of Unknown Origin (PUO) -- 15.7 Involvement of Other Systems in Brucellosis [16] -- 15.8 Treatment of Osteoarticular Brucellosis -- 15.9 Conclusion -- References -- 16: Hypertrophic Osteoarthropathy -- 16.1 Introduction -- 16.2 Etiology -- 16.3 Clinical Features -- 16.4 Investigations -- 16.5 Pathophysiology -- 16.6 Management -- 16.7 Conclusion -- References -- 17: Carcinomatous Polyarthritis -- 17.1 Introduction -- 17.2 Pathophysiology -- 17.3 Clinical Features (Table 17.1) -- 17.3.1 When to Suspect Carcinomatous Polyarthritis? -- 17.3.2 Common Patterns of Presentation -- 17.3.3 Risk Factors and Extra-Articular Features Suggestive of Carcinomatous Polyarthritis -- 17.3.4 Types of Malignancies Commonly Associated with Carcinomatous Polyarthritis -- 17.3.5 Differential Diagnosis -- 17.4 Investigations -- 17.5 Management -- 17.6 Conclusion -- References -- 18: Arthritis Associated with Immune Checkpoint Inhibitors -- 18.1 Introduction -- 18.2 Epidemiology -- 18.3 Risk Factors -- 18.4 Pathogenesis -- 18.5 Clinical Features -- 18.6 Diagnosis -- 18.7 Differential Diagnosis -- 18.8 Management -- 18.9 Conclusion -- References -- 19: Miscellaneous Arthropathies -- 19.1 Introduction -- 19.2 Amyloid Arthropathy -- 19.3 Sickle Cell Disease-Associated Arthropathy -- 19.4 Jaccoud's Arthropathy -- 19.5 Arthritis Robustus -- 19.6 Conclusion -- References -- Index. |
|
|
|
|
|
| |